Related references
Note: Only part of the references are listed.A Phase 1 Study of KH902, a Vascular Endothelial Growth Factor Receptor Decoy, for Exudative Age-Related Macular Degeneration
Ming Zhang et al.
OPHTHALMOLOGY (2011)
Heterogeneity in primary tumors and corresponding metastases: could it provide us with any hints to personalize cancer therapy?
Ketao Jin et al.
PERSONALIZED MEDICINE (2011)
Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review
Ketao Jin et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2010)
Prevalence and Heterogeneity of KRAS, BRAF, and PIK3CA Mutations in Primary Colorectal Adenocarcinomas and Their Corresponding Metastases
Stephan E. Baldus et al.
CLINICAL CANCER RESEARCH (2010)
A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases
Sara E. Monaco et al.
HUMAN PATHOLOGY (2010)
Advances in Combination of Antiangiogenic Agents Targeting VEGF-binding and Conventional Chemotherapy and Radiation for Cancer Treatment
Li-Song Teng et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2010)
Personalized cancer therapy using a patient-derived tumor tissue xenograft model: a translational field worthy of exploring further?
Ketao Jin et al.
PERSONALIZED MEDICINE (2010)
Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant
F. Molinari et al.
BRITISH JOURNAL OF CANCER (2009)
PTEN Expression and KRAS Mutations on Primary Tumors and Metastases in the Prediction of Benefit From Cetuximab Plus Irinotecan for Patients With Metastatic Colorectal Cancer
Fotios Loupakis et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Discordance of Molecular Biomarkers Associated with Epidermal Growth Factor Receptor Pathway between Primary Tumors and Lymph Node Metastasis in Non-small Cell Lung Cancer
Sarah Park et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
The Pharmacology Study of a New Recombinant Human VEGF Receptor-Fc Fusion Protein on Experimental Choroidal Neovascularization
Ming Zhang et al.
PHARMACEUTICAL RESEARCH (2009)
Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastases
Argun Akcakanat et al.
CANCER (2008)
Heterogeneity of breast cancer metastases: Comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases
Julie M. Wu et al.
CLINICAL CANCER RESEARCH (2008)
Establishment of Patient-Derived Non-Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive Biomarkers
Iduna Fichtner et al.
CLINICAL CANCER RESEARCH (2008)
Epidermal growth factor receptor (EGFR) downstream signalling pathway in primary colorectal tumours and related metastatic sites: optimising EGFR-targeted treatment options
M. Scartozzi et al.
BRITISH JOURNAL OF CANCER (2007)
Establishment of human tumor xenografts in immunodeficient mice
Christopher L. Morton et al.
NATURE PROTOCOLS (2007)
HER2 gene status in primary breast cancers and matched distant metastases
Coya Tapia et al.
BREAST CANCER RESEARCH (2007)
Rapid vascular regrowth in tumors after reversal of VEGF inhibition
Michael R. Mancuso et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
An in vivo platform for translational drug development in pancreatic cancer
Belen Rubio-Viqueira et al.
CLINICAL CANCER RESEARCH (2006)
Contributions of human tumor xenografts to anticancer drug development
EA Sausville et al.
CANCER RESEARCH (2006)
An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line
YW Wang et al.
LABORATORY INVESTIGATION (2005)
Sensitive Sequencing method for KRAS mutation detection by pyrosequencing
S Ogino et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2005)
Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma
Y Gong et al.
CANCER (2005)
Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer
S Schneider et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2005)
Age-related changes in vascular endothelial growth factor dependency and angiopoietin-1 - Induced plasticity of adult blood vessels
F Baffert et al.
CIRCULATION RESEARCH (2004)
Change of HER-2/neu status in a subset of distant metastases from breast carcinomas
P Regitnig et al.
JOURNAL OF PATHOLOGY (2004)
Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: Implications for treatment with EGFR-targeted monoclonal antibodies
M Scartozzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors
P Baluk et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma
C Bozzetti et al.
CANCER CYTOPATHOLOGY (2003)
Regression of established tumors and metastases by potent vascular endothelial growth factor blockade
JZ Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites
D Gancberg et al.
ANNALS OF ONCOLOGY (2002)
Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors
S Morikawa et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials
JI Johnson et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
